If you’ve been researching fertility after 35, chances are you’ve come across the term AMH — anti-Müllerian hormone. It’s become one of the most commonly discussed fertility markers in recent years, and for good reason: it provides a window into ovarian reserve, or the remaining egg supply. But AMH results are frequently misunderstood, and a single number — without clinical context — can cause unnecessary anxiety or, conversely, false reassurance.
This article aims to explain what AMH actually measures, what the evidence says about its limitations, and how to think about your results in the context of trying to conceive after 35. As with all fertility testing, the most meaningful interpretation happens in conversation with a qualified reproductive endocrinologist or OB/GYN.
What AMH Measures — and What It Doesn’t
AMH is a hormone produced by cells in the follicles (fluid-filled sacs containing developing eggs) in the ovaries. The amount of AMH in the blood correlates with the number of antral follicles present, which in turn reflects the size of the remaining egg supply — what’s called ovarian reserve.
According to research published in medical literature and referenced by the American Society for Reproductive Medicine, AMH is considered a more stable marker of ovarian reserve than other tests (such as cycle day 3 FSH) because it doesn’t fluctuate as much across the menstrual cycle. This stability makes it a useful clinical tool.
However, AMH has a critical limitation that’s often underemphasized: it measures quantity, not quality. Egg quality — the chromosomal integrity of eggs, which is what most significantly affects fertilization success and miscarriage risk — is not reflected in AMH levels. A woman with a low AMH may still have eggs of excellent quality; a woman with a high AMH may have quality issues. This distinction matters enormously for how results should be interpreted.
How AMH Levels Change With Age
AMH levels naturally decline with age as the ovarian reserve decreases. Research shows that average AMH levels in women in their late 30s are lower than in women in their 20s, and they continue to decline through the 40s. However, there’s considerable variation — some women in their late 30s have AMH levels similar to those in their late 20s, while others show more significant decline.
Reference ranges also vary by laboratory, which means a result that falls “low” at one lab may be categorized differently elsewhere. Understanding what ovarian reserve testing involves — including AMH alongside antral follicle count via ultrasound — helps provide a more complete picture than any single number.
The Difference Between Diminished Reserve and Infertility
This is perhaps the most important nuance around AMH testing: a lower-than-average AMH for age does not equal infertility. Many women with low or low-normal AMH conceive naturally or with minimal assistance. What diminished ovarian reserve may suggest is a smaller window of time in which natural conception is more likely, and potentially a different response to ovarian stimulation medications if IVF is pursued. A reproductive endocrinologist is best placed to discuss what your specific results mean for your individual situation.
AMH and IVF: A Closer Look
AMH is most clinically useful in the context of assisted reproductive technology, particularly IVF. Fertility clinics use AMH levels (alongside antral follicle count) to predict how many eggs are likely to be retrieved during an IVF cycle and to calibrate medication dosages accordingly. Women with lower AMH may produce fewer eggs per cycle, which can affect IVF planning — but does not determine whether IVF will ultimately be successful, which depends on many additional factors including egg quality, sperm factors, uterine environment, and embryo development.
Some women with quite low AMH have successful IVF cycles; others with higher AMH face challenges due to quality factors. This is why treating AMH as a simple “fertility score” understates its complexity and can lead to unnecessary distress or overconfidence.
Getting Tested: Practical Considerations
AMH testing involves a simple blood draw and can typically be done at any point in the menstrual cycle (unlike some other hormone tests). Results are usually available within a few days. Many OB/GYN offices and all reproductive endocrinology practices offer this test.
If you’re over 35 and considering having children in the next year or two, or if you have specific concerns about your fertility, asking your doctor about AMH testing is a reasonable conversation to have. The results can help inform decisions about timing and whether to pursue a more comprehensive fertility evaluation.
What to Ask Your Provider
When discussing AMH results with your doctor, some useful questions include: How does my result compare to age-matched norms? What does this suggest about my approximate window for conception? Are there other tests you’d recommend alongside this? If results are concerning, what would the next steps look like? These questions can help transform a number into a useful piece of your fertility picture rather than a source of anxiety.
When AMH Testing May Be Particularly Relevant
While AMH testing is not universally recommended for all women, it may be particularly relevant if: you’re over 35 and beginning to think about conception; you have a family history of early menopause; you’ve previously had ovarian surgery, chemotherapy, or radiation; you’ve experienced unexplained fertility challenges; or you’re exploring egg freezing as an option. In all of these contexts, ovarian reserve information can help guide conversations with your healthcare team.
For women exploring egg freezing as a fertility preservation option after 35, AMH testing is typically a key part of the initial assessment to understand how the ovaries may respond to stimulation.
Frequently Asked Questions
Can AMH levels improve or increase over time?
AMH levels generally follow a declining trajectory over time as ovarian reserve decreases with age. While some research has examined whether certain interventions might influence AMH, the evidence for reliably increasing AMH is not established. It’s considered a biological marker of where you currently are, not a number that can be significantly changed through lifestyle interventions.
Is a low AMH a reason to start fertility treatment immediately?
Not necessarily. A low AMH is one piece of information in a larger fertility picture. Many women with lower AMH conceive naturally. However, if you’re over 35 with lower ovarian reserve, a reproductive endocrinologist can help you understand your specific situation and discuss whether and when to consider pursuing assistance. Timing awareness — without panic — is the goal.
Do I need an AMH test before trying to conceive?
Routine AMH testing before trying to conceive is not universally recommended for all women. However, for women over 35, or those with risk factors for diminished ovarian reserve, it can provide useful information. Your healthcare provider can advise whether it makes sense for your individual circumstances.
If my AMH is normal for my age, does that mean I’ll be able to conceive easily?
AMH within an age-appropriate range is generally reassuring about ovarian reserve, but it doesn’t guarantee conception. Fertility depends on multiple factors — egg quality, partner fertility, uterine health, and others — that AMH doesn’t assess. It’s one piece of a complex picture.
Key Takeaways
- AMH measures ovarian reserve (egg quantity) but does not reflect egg quality, which is the key determinant of fertility outcomes — especially after 35.
- AMH levels naturally decline with age, but individual variation is significant; lower AMH doesn’t mean inability to conceive.
- AMH is most clinically useful in ART planning, particularly for predicting IVF egg retrieval response and calibrating medication.
- Results should always be interpreted by a healthcare provider in the context of your full clinical picture, not as a standalone fertility score.
- If you’re over 35 and considering your fertility timeline, asking about AMH testing is a reasonable conversation to start with your OB/GYN or reproductive endocrinologist.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.